Lilly wins Alimta Vitamin Regimen Patent Lawsuit against Apotex Inc

By Akshay Kedari  | Date: 2019-12-31

Lilly wins Alimta Vitamin Regimen Patent Lawsuit against Apotex Inc

 

  • Ruling by the US District Court has concluded that Apotex Inc. would be infringing the Alimta vitamin regimen patent by launching its proposed products until the patent expiration of Lilly
     
  • The ruling would bar Apotex from marketing its alternative product until the patent expiration in May 2022

American pharmaceutical company, Eli Lilly and Company, announced that the U.S. District Court (Southern District of Indiana) decided in favor of the company in the Alimta Vitamin Regimen Patent Lawsuit. The court's verdict states that Apotex Inc, a competitor would be liable for infringement of Alimta vitamin regimen patent in the event the company selling generics of the drug prior to the expiration of the patent in May 2022. 

 

Apotex is a Canadian pharmaceutical corporation producing high-quality, affordable generic, as well as innovative pharmaceuticals, for patients across the globe. The ruling would prevent Apotex from marketing its generic form of the lung cancer drug Alimta. Lilly expects the competitor company to appeal the ruling. 

 

For the record, Alimta vitamin regimen is categorized as an antifolate drug, which is designed to bar cells from making DNA through the use of folic acid.

 

Lilly's senior vice president and general counsel, Michael J. Harrington was quoted saying that the company is pleased with the District Court's ruling finding the competitor’s proposition to be a case of infringement. Commenting further on the verdict Harrington stated that Lilly deserves intellectual property protection for its extensive research efforts concentrated on the discovery of the Alimta vitamin regimen. 

 

The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office had also ruled in favor of the company in 2017. Similarly, the U.S. Court of Appeals for the Federal Circuit also upheld the validity of the patent in 2017. 

 

Source credit:

https://investor.lilly.com/news-releases/news-release-details/us-district-court-rules-favor-lilly-alimta-vitamin-regimen-0

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More >>

More News By Akshay Kedari

Alipay+ allies with Asian E-Wallets to boost cashless travel in South Korea

Alipay+ allies with Asian E-Wallets to boost cashless travel in South Korea

By Akshay Kedari

Amidst rising efforts for promoting cashless travel, prominent mobile payment providers in Asia have recently announced an integration of the cross-border digitalized payment solutions from Alipay+ in South Korea. With this move, users of e-wallet...

Seracle, Sumsub partner for offering enhanced KYC protocols and cybersecurity

Seracle, Sumsub partner for offering enhanced KYC protocols and cybersecurity

By Akshay Kedari

Sumsub will assist Seracle in building an innovative blockchain ecosystem Sumsub will offer enhanced security to Seracle at a time when losses due to cryptocurrency thefts have increased by about 60% to $1.9 billion Seracle, a global blockc...

CATL unveils new Module to Bracket tech for heavy-duty electric trucks

CATL unveils new Module to Bracket tech for heavy-duty electric trucks

By Akshay Kedari

CATL, a Chinese battery manufacturer and technology company, has reportedly introduced a new battery technology known as Module to Bracket (MTB) for heavy-duty electric trucks. As per reliable sources, the MTB technology deploys the battery module...

Arbonics nabs $1.7M to launch data & science-driven tool for landowners

Arbonics nabs $1.7M to launch data & science-driven tool for landowners

By Akshay Kedari

Arbonics, a Tallinn, Estonia-based climate tech startup, is launching a new innovative data and science-driven tool to ensure that the potential carbon income from land and forests is calculated quickly and easily for landowners in Europe to assist i...

Cruise to unveil robotaxi service in Austin and Phoenix by 2022

Cruise to unveil robotaxi service in Austin and Phoenix by 2022

By Akshay Kedari

Cruise, an American self-driving technology unit, is reportedly all set to unveil commercial robotaxi services across Phoenix, and Austin, Texas, two major spots for autonomous vehicle development, in the next 3 months before 2022 ends. During Gol...